Results 241 to 250 of about 24,537 (326)

Oral Squamous Cell Carcinoma‐Risk Factors, Diagnosis, Treatment, and Prevention

open access: yesCancer Nexus, Volume 2, Issue 2, April 2026.
ABSTRACT Oral squamous cell carcinoma (OSCC) usually originates from the precancerous lesions of oral mucosa and accounts for approximately 90% of oral cancers. In‐depth understanding of pathogenesis, hallmarks, and etiological factors is a crucial prerequisite for advancing the diagnosis and treatment for OSCC patients. This review aims to present the
Liping Wang   +4 more
wiley   +1 more source

Neurophysiological findings in a patient with adrenomyeloneuropathy [PDF]

open access: yes, 1986
Brosi, K.   +3 more
core  

Novel insights into extracellular vesicles: An update on biomolecules, immunomodulation and clinical strategies in skin melanoma

open access: yesClinical and Translational Medicine, Volume 16, Issue 4, April 2026.
Extracellular vesicles mediate melanoma progression by transferring biomolecules (proteins, nucleic acids) that reshape the tumour microenvironment, promote immune evasion and drive metastasis. They also serve as diagnostic biomarkers and engineered therapeutic carriers for targeted therapy.
Junshu Li   +3 more
wiley   +1 more source

Synchrotron‐generated microbeams as a radiosurgical alternative for drug‐resistant epilepsies: Proof of concept in a mouse model of mesiotemporal lobe epilepsy

open access: yesEpilepsia, Volume 67, Issue 4, Page 1614-1626, April 2026.
Abstract Objective One‐third of patients with epilepsy, particularly those with mesial temporal lobe epilepsy (MTLE), remain resistant to medication. Resective surgery, the gold standard, is highly invasive and carries significant risks. Here, using a mouse model, we explored the potential of microbeam radiation therapy (MRT), a new technique based on ...
Loan Samalens   +8 more
wiley   +1 more source

Queilitis actínica: aspectos histológicos, clínicos y epidemiológicos

open access: yesRevista Cubana de Estomatología
Carolina Hernández Osorio   +2 more
doaj  

Home - About - Disclaimer - Privacy